MPM Capital Announces Immuno-Oncology Pioneer Patrick Baeuerle To Serve As Managing Director

BOSTON--(BUSINESS WIRE)--MPM Capital today announces the appointment of Dr. Patrick A. Baeuerle as Managing Director, effective April 1, 2015. A renowned pioneer in the development of T-cell based human therapies for cancer and a proven drug-developer, Dr. Baeuerle extends MPM expertise in assessing the science behind breakthrough discoveries and drugs that can lead to new treatments and cures.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC